トファシチニブ使用時の帯状疱疹は、グルココルチコイド併用でさらに増加するが、メソトレキセートでは増加しない
Arthritis Care Res 2018 DOI 10.1002/acr.23769
The rate of Herpes Zoster (HZ) in tofacitinib (TOF) users with concomitant glucocorticoids (GC) was approximately double that of other TOF combination therapies.TOF is an effective treatment for RA. Increased HZ risk has been observed with the use of JAK inhibitors, whereas the HZ risk with biologics and targeted RA therapies are comparable. This study evaluated the HZ risk in TOF users according to concomitant GC, MTX, both, or neither. MarketScan and Medicare data were used to identify 8030 rh...